Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 208


Obituary and Tribute to John "Jack" Francis Fowler, PhD, DSc (1925-2016).

Harari PM, Ritter MA, van der Kogel AJ.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):886-888. doi: 10.1016/j.ijrobp.2017.01.015. Epub 2017 Jan 10. No abstract available.


Potential role of the glycolytic oscillator in acute hypoxia in tumors.

Fru LC, Adamson EB, Campos DD, Fain SB, Jacques SL, van der Kogel AJ, Nickel KP, Song C, Kimple RJ, Kissick MW.

Phys Med Biol. 2015 Dec 21;60(24):9215-25. doi: 10.1088/0031-9155/60/24/9215. Epub 2015 Nov 18.


Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors.

Stegeman H, Rademakers SE, Span PN, Takes RP, van der Kogel AJ, Kaanders JH, Bussink J.

Head Neck. 2014 Sep;36(9):1288-95. doi: 10.1002/hed.23446. Epub 2013 Nov 6.


Systematic analysis of 18F-FDG PET and metabolism, proliferation and hypoxia markers for classification of head and neck tumors.

Hoeben BA, Starmans MH, Leijenaar RT, Dubois LJ, van der Kogel AJ, Kaanders JH, Boutros PC, Lambin P, Bussink J.

BMC Cancer. 2014 Feb 26;14:130. doi: 10.1186/1471-2407-14-130.


Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trial.

Rademakers SE, Hoogsteen IJ, Rijken PF, Terhaard CH, Doornaert PA, Langendijk JA, van den Ende P, van der Kogel AJ, Bussink J, Kaanders JH.

Head Neck. 2015 Feb;37(2):171-6. doi: 10.1002/hed.23569. Epub 2014 Feb 12.


Combining radiotherapy with MEK1/2, STAT5 or STAT6 inhibition reduces survival of head and neck cancer lines.

Stegeman H, Kaanders JH, Verheijen MM, Peeters WJ, Wheeler DL, Iida M, Grénman R, van der Kogel AJ, Span PN, Bussink J.

Mol Cancer. 2013 Nov 5;12(1):133. doi: 10.1186/1476-4598-12-133.


Paralysis following stereotactic spinal irradiation in pigs suggests a tolerance constraint for single-session irradiation of the spinal nerve.

Medin PM, Foster RD, van der Kogel AJ, Meyer J, Sayre JW, Huang H, Öz OK.

Radiother Oncol. 2013 Oct;109(1):107-11. doi: 10.1016/j.radonc.2013.08.025. Epub 2013 Sep 20.


EGFR-inhibition enhances apoptosis in irradiated human head and neck xenograft tumors independent of effects on DNA repair.

Stegeman H, Span PN, Cockx SC, Peters JP, Rijken PF, van der Kogel AJ, Kaanders JH, Bussink J.

Radiat Res. 2013 Oct;180(4):414-21. doi: 10.1667/RR3349.2. Epub 2013 Sep 23.


Dasatinib Inhibits DNA Repair after Radiotherapy Specifically in pSFK-Expressing Tumor Areas in Head and Neck Xenograft Tumors.

Stegeman H, Span PN, Rijken PF, Cockx SC, Wheeler DL, Iida M, van der Kogel AJ, Kaanders JH, Bussink J.

Transl Oncol. 2013 Aug 1;6(4):413-9. Print 2013 Aug.


The PERK/ATF4/LAMP3-arm of the unfolded protein response affects radioresistance by interfering with the DNA damage response.

Nagelkerke A, Bussink J, van der Kogel AJ, Sweep FC, Span PN.

Radiother Oncol. 2013 Sep;108(3):415-21. doi: 10.1016/j.radonc.2013.06.037. Epub 2013 Jul 25.


Epidermal growth factor receptor expression in laryngeal cancer predicts the effect of hypoxia modification as an additive to accelerated radiotherapy in a randomised controlled trial.

Nijkamp MM, Span PN, Terhaard CH, Doornaert PA, Langendijk JA, van den Ende PL, de Jong M, van der Kogel AJ, Bussink J, Kaanders JH.

Eur J Cancer. 2013 Oct;49(15):3202-9. doi: 10.1016/j.ejca.2013.06.024. Epub 2013 Jul 15.


Evaluation and immunohistochemical qualification of carbogen-induced ΔR₂ as a noninvasive imaging biomarker of improved tumor oxygenation.

Baker LC, Boult JK, Jamin Y, Gilmour LD, Walker-Samuel S, Burrell JS, Ashcroft M, Howe FA, Griffiths JR, Raleigh JA, van der Kogel AJ, Robinson SP.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):160-7. doi: 10.1016/j.ijrobp.2013.04.051. Epub 2013 Jul 9.


Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial.

Rademakers SE, Hoogsteen IJ, Rijken PF, Oosterwijk E, Terhaard CH, Doornaert PA, Langendijk JA, van den Ende P, Takes R, De Bree R, van der Kogel AJ, Bussink J, Kaanders JH.

Radiother Oncol. 2013 Sep;108(3):517-22. doi: 10.1016/j.radonc.2013.04.022. Epub 2013 May 26.


PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS.

Rouschop KM, Dubois LJ, Keulers TG, van den Beucken T, Lambin P, Bussink J, van der Kogel AJ, Koritzinsky M, Wouters BG.

Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4622-7. doi: 10.1073/pnas.1210633110. Epub 2013 Mar 7.


Predictive value of hypoxia, proliferation and tyrosine kinase receptors for EGFR-inhibition and radiotherapy sensitivity in head and neck cancer models.

Stegeman H, Kaanders JH, van der Kogel AJ, Iida M, Wheeler DL, Span PN, Bussink J.

Radiother Oncol. 2013 Mar;106(3):383-9. doi: 10.1016/j.radonc.2013.02.001. Epub 2013 Feb 28.


Bioeffect modeling and equieffective dose concepts in radiation oncology--terminology, quantities and units.

Bentzen SM, Dörr W, Gahbauer R, Howell RW, Joiner MC, Jones B, Jones DT, van der Kogel AJ, Wambersie A, Whitmore G.

Radiother Oncol. 2012 Nov;105(2):266-8. doi: 10.1016/j.radonc.2012.10.006. Epub 2012 Nov 15.


Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck.

Stegeman H, Kaanders JH, Wheeler DL, van der Kogel AJ, Verheijen MM, Waaijer SJ, Iida M, Grénman R, Span PN, Bussink J.

BMC Cancer. 2012 Oct 10;12:463. doi: 10.1186/1471-2407-12-463.


Spinal cord tolerance to single-session uniform irradiation in pigs: implications for a dose-volume effect.

Medin PM, Foster RD, van der Kogel AJ, Sayre JW, McBride WH, Solberg TD.

Radiother Oncol. 2013 Jan;106(1):101-5. doi: 10.1016/j.radonc.2012.08.007. Epub 2012 Sep 14.


(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry.

Hansen AE, Kristensen AT, Jørgensen JT, McEvoy FJ, Busk M, van der Kogel AJ, Bussink J, Engelholm SA, Kjær A.

Radiat Oncol. 2012 Jun 15;7:89. doi: 10.1186/1748-717X-7-89.


Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer.

Røe K, Mikalsen LT, van der Kogel AJ, Bussink J, Lyng H, Ree AH, Marignol L, Olsen DR.

Radiat Oncol. 2012 May 23;7:75. doi: 10.1186/1748-717X-7-75.

Supplemental Content

Loading ...
Support Center